McIlrath & Eck’s Medpace MEDP Stock Holding History

McIlrath & Eck’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-161	Closed	-$30K	–	821
2021 Q3	$30K	Hold	161	–	–	0.01%	312
2021 Q2	$28K	Hold	161	–	–	0.01%	326
2021 Q1	$26K	Hold	161	–	–	0.01%	301
2020 Q4	$22K	Hold	161	–	–	0.01%	285
2020 Q3	$18K	Hold	161	–	–	0.01%	283
2020 Q2	$15K	Hold	161	–	–	0.01%	287
2020 Q1	$12K	Hold	161	–	–	0.01%	278
2019 Q4	$14K	Hold	161	–	–	0.01%	303
2019 Q3	$14K	Hold	161	–	–	0.01%	281
2019 Q2	$9K	Hold	161	–	–	0.01%	358
2019 Q1	$9K	Buy	+161	New	+$9.62K	0.01%	358

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

McIlrath & Eck's MEDP Position: Q4 2021 in Review

McIlrath & Eck sold out of Medpace (MEDP) in Q4 2021, closing a stake of 161 shares — an estimated $30K sold.

McIlrath & Eck first reported a position in MEDP in Q1 2019 and held it in 11 quarters. The position peaked at $30K in Q3 2021. 386 funds tracked by Wall St. Rank hold MEDP as of Q4 2021.

McIlrath & Eck reported no remaining Medpace position as of Q4 2021 after selling out during the quarter.
McIlrath & Eck sold 161 Medpace shares in Q4 2021, an estimated $30K.
McIlrath & Eck first reported a position in Medpace in Q1 2019 and held it in 11 quarters.
McIlrath & Eck's Medpace position peaked at $30K in Q3 2021.
386 funds tracked by Wall St. Rank held Medpace as of Q4 2021.

Based on McIlrath & Eck's 13F filing for Q4 2021, filed 8 Feb 2022.